Aurora Private Wealth Inc. Invests $1.70 Million in Koninklijke Philips N.V. (NYSE:PHG)

Aurora Private Wealth Inc. purchased a new stake in shares of Koninklijke Philips N.V. (NYSE:PHG) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 66,726 shares of the technology company’s stock, valued at approximately $1,695,000.

Several other large investors have also recently bought and sold shares of the business. Dimensional Fund Advisors LP boosted its position in Koninklijke Philips by 2.0% during the 4th quarter. Dimensional Fund Advisors LP now owns 4,290,051 shares of the technology company’s stock worth $108,624,000 after acquiring an additional 85,994 shares during the period. Connor Clark & Lunn Investment Management Ltd. boosted its holdings in shares of Koninklijke Philips by 87.7% during the fourth quarter. Connor Clark & Lunn Investment Management Ltd. now owns 2,222,192 shares of the technology company’s stock worth $56,266,000 after purchasing an additional 1,038,321 shares during the period. Northern Trust Corp boosted its holdings in shares of Koninklijke Philips by 36.6% during the fourth quarter. Northern Trust Corp now owns 1,608,749 shares of the technology company’s stock worth $40,734,000 after purchasing an additional 430,757 shares during the period. Causeway Capital Management LLC grew its position in Koninklijke Philips by 24.0% during the fourth quarter. Causeway Capital Management LLC now owns 1,566,850 shares of the technology company’s stock valued at $39,673,000 after purchasing an additional 303,428 shares in the last quarter. Finally, Becker Capital Management Inc. increased its stake in Koninklijke Philips by 0.7% in the 4th quarter. Becker Capital Management Inc. now owns 945,542 shares of the technology company’s stock valued at $23,941,000 after buying an additional 6,475 shares during the period. 13.67% of the stock is owned by institutional investors and hedge funds.

Koninklijke Philips Trading Down 1.4%

Shares of NYSE PHG opened at $24.17 on Friday. The stock has a market cap of $23.27 billion, a price-to-earnings ratio of 56.21, a PEG ratio of 0.69 and a beta of 0.76. The business has a 50 day simple moving average of $23.72 and a 200 day simple moving average of $25.01. Koninklijke Philips N.V. has a 52 week low of $20.61 and a 52 week high of $31.57. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.79 and a current ratio of 1.28.

Koninklijke Philips (NYSE:PHG) last posted its earnings results on Tuesday, May 6th. The technology company reported $0.27 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.14 by $0.13. Koninklijke Philips had a net margin of 2.11% and a return on equity of 10.97%. The firm had revenue of $4.31 billion during the quarter, compared to analysts’ expectations of $4.10 billion. During the same period in the previous year, the company earned $0.21 earnings per share. The company’s revenue was down 1.0% compared to the same quarter last year. On average, research analysts predict that Koninklijke Philips N.V. will post 1.63 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the stock. Wall Street Zen lowered shares of Koninklijke Philips from a “buy” rating to a “hold” rating in a research note on Sunday, June 15th. Sanford C. Bernstein raised Koninklijke Philips from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, March 18th. Two equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy”.

Koninklijke Philips Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.